No. | Recommendation | Keyword |
R18 | Opioids present hazards for adolescents (Grade B). A trial of opioid therapy may be considered for adolescent patients with well-defined somatic or neuropathic pain conditions when non-opioid alternatives have failed, risk of opioid misuse is assessed as low, close monitoring is available, and consultation, if feasible, is included in the treatment plan (Grade C). | Adolescent patients |
Non-medical use (misuse) of opioids is more common among adolescents, and may be a risk factor for future opioid addiction. Among adolescents, risk factors for opioid misuse include poor academic performance; higher risk-taking levels; major depression; and regular use of alcohol, cannabis, and nicotine (Schepis 2008).
Misuse and overdose are the greatest risks for adolescents. To reduce these risks:
In 2007, researchers from the Centre for Addiction and Mental Health in Toronto ON released the "Ontario Student Drug Use and Health Survey." They found that 21% of Ontario students in grades 7 to 12 report using prescription opioid pain relievers such as Tylenol® No. 3 and Percocet® for non-medical purposes; almost 72% report obtaining the drugs from home. In addition, among all drugs asked about, OxyContin® was the only drug to show a significant, but small, increase in non-medical use since the last survey (2% of students reported using it in 2007, representing about 18,100 students, compared to 1% in 2005) (Adlaf 2006).
One study from Michigan documented that 12% of high-school students had used opioids in the past year (Boyd 2006). Another study documented that the risk of developing prescription drug abuse and dependence later is correlated with the age of first exposure to opioids (McCabe 2007).
Among adolescents, risk factors for opioid misuse include poor academic performance; higher risk-taking levels; major depression; and regular use of alcohol, cannabis, and nicotine (Schepis 2008).